Showing 141-150 of 834 results for "".
Scurvy in the Modern Era
https://practicaldermatology.com/topics/general-topics/scurvy-in-the-modern-era/21456/One of the winning presentations given by dermatology residents at Cosmetic Surgery Forum.Can Prescription Hyperhidrosis Treatments Help Mitigate Symptoms?
https://practicaldermatology.com/issues/novemberdecember-2025/can-prescription-hyperhidrosis-treatments-help-mitigate-symptoms/48890/Clinicians should begin to think beyond standard protocols and recognize sweat management as a potentially powerful tool in their therapeutic arsenal.Update on Atopic Dermatitis 2018
https://practicaldermatology.com/topics/general-topics/update-on-atopic-dermatitis-2018/20354/A look at the pathophysiology of AD, including structural and immunologic contributors, as well as new therapeutic developments with an eye toward breakthroughs on the horizon.Hispanic Home Remedies (remedios caseros) in the Management of Dermatologic Disease: A Focused Review
https://practicaldermatology.com/columns/clinical-focus-1/hispanic-home-remedies-iremedios-caserosi-in-the-management-of-dermatologic-disease-a-focused-review/23718/Chamomile, aloe vera, green tea, honey, and apple cider vinegar are popular remedios caseros.A Global Approach to Perioral Rejuvenation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-global-approach-to-perioral-rejuvenation/18615/Joel L.Cohen, MD, Director of AboutSkin Dermatology and DermSurgery in Englewood and Lone Tree, CO, discusses the new thinking about perioral rejuvenation at the Cosmetic Surgery Forum 2015 in Las Vegas. He shares techniques for a combination approach for the best, most natural results for enhancingRhatigan to Merz, MOC Dissatisfaction, Syneron-Candela Sale
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhatigan-to-merz-moc-dissatisfaction-syneron-candela-sale/18485/Industry veteran Bob Rhatigan is the new President and Chief Executive Officer of Merz North America. Patrick Urban is new Chief Commercial Officer. In a transaction valued at approximately $397 million, an affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of SyCase Study: A Verrucous Plaque of the Nose
https://practicaldermatology.com/topics/practice-management/case-study-a-verrucous-plaque-of-the-nose/21101/What caused a progressively enlarging mass starting along the nasal septum and extending to the sidewall?The Microbiome in Acne: Where are We Now?
https://practicaldermatology.com/topics/acne-rosacea/the-microbiome-in-acne-where-are-we-now/23731/As research reveals connections of the microbiome to skin disease, clinicians may discover new approaches to managing the disease.A History of Phlebology: Warts and All, Part 3
https://practicaldermatology.com/topics/practice-management/a-history-of-phlebology-warts-and-all-part-3/20843/Treatment of Psychodermatological Conditions Using N-acetylcysteine
https://practicaldermatology.com/columns/physician-spotlight/treatment-of-psychodermatological-conditions-using-n-acetylcysteine/23998/The low risk, high reward of NAC suggests its great promise in a supplementary role for treatment of trichotillomania and excoriation disorder.